In the BioHarmony Drug Report Database

"Preview" Icon

Ganciclovir

Cytovene, Ganzyk-rtu, Vitrasert, Zirgan (ganciclovir) is a small molecule pharmaceutical. Ganciclovir was first approved as Cytovene on 1994-12-22. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Cytovene iv’s patent is valid until 2034-09-02 (FDA).

 

Trade Name

 

Cytovene, Ganzyk-rtu, Vitrasert, Zirgan
 

Common Name

 

ganciclovir
 

ChEMBL ID

 

CHEMBL182
 

Indication

 

aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis
 

Drug Class

 

Antivirals: antivirals (acyclovir type)

Image (chem structure or protein)

Ganciclovir structure rendering